Updated Jul 16, 2026
SEKHRI PAUL J has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $84K. Historical track record: 1/5 stars across 3 tracked purchases.

Paul J. Sekhri is a seasoned executive in the life sciences and biotechnology sectors, currently serving as the President and CEO of Veeva Systems Inc. He has held various leadership roles across multiple companies, including VTV Therapeutics and Longboard Pharmaceuticals, contributing to advancements in cloud-based software solutions for the life sciences industry.
| Role | Director |
|---|---|
| Notability | 50/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 0% |
| 90-day win rate | 10000% |
| Avg 5-day return | -1114.10% |
| Avg 30-day return | -1141.49% |
| Avg 90-day return | +1966.81% |
| Best 30-day return | -1126.44% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-03 | VEEV | VEEVA SYSTEMS INC | M — Option exercise | 253 | $0.00 | |
| 2026-03-03 | VEEV | VEEVA SYSTEMS INC | M — Option exercise | 253 | $0.00 | |
| 2025-09-01 | VEEV | VEEVA SYSTEMS INC | M — Option exercise | 253 | $0.00 | |
| 2025-06-01 | VEEV | VEEVA SYSTEMS INC | M — Option exercise | 329 | $0.00 | |
| 2024-12-02 | VEEV | VEEVA SYSTEMS INC | M — Option exercise | 329 | $0.00 | |
| 2024-11-19 | VTVT | vTv Therapeutics Inc. | P — Open-market purchase [10b5-1] | 1.8K | $16.96 | $31K |
| 2024-11-19 | VTVT | vTv Therapeutics Inc. | P — Open-market purchase [10b5-1] | 1.8K | $16.88 | $30K |
| 2024-11-19 | VTVT | vTv Therapeutics Inc. | P — Open-market purchase [10b5-1] | 1.4K | $16.35 | $23K |
Paul J. Sekhri is a seasoned executive in the life sciences and biotechnology sectors, currently serving as the President and CEO of Veeva Systems Inc. He has held various leadership roles across multiple companies, including VTV Therapeutics and Longboard Pharmaceuticals, contributing to advancements in cloud-based software solutions for the life sciences industry.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 3 open-market purchases ($84K) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, SEKHRI PAUL J averaged -1141.5% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SEKHRI PAUL J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.